Susan Blaney, MD, is a pediatric oncologist who has dedicated her clinical and research career to developing novel therapies for recurrent or refractory cancers, particularly those affecting the central nervous system.
Over the course of her career, she has served as Director of the Texas Children’s Cancer Center and Division Chief of Pediatric Oncology at Baylor College of Medicine (BCM), as well as Vice Chair of the NCI-funded Children’s Oncology Group (COG) and Chair of its Phase 1 and Pilot Consortium. She also held several leadership roles at BCM, including Vice President of Clinical and Translational Research, Associate Chair for Clinical Research at the Dan L. Duncan Comprehensive Cancer Center, and Executive Vice Chair of the Department of Pediatrics.
Dr. Blaney has served on the National Cancer Institute’s Clinical Trials Advisory Committee and Investigational Drug Steering Committee, and as a consultant to the FDA’s Pediatric Oncology Drug Advisory Committee. She has contributed to numerous national oncology and pediatric organizations and has received multiple endowed chairs and professional honors, including the Distinguished Faculty Award from BCM’s Alumni Association and the U.S. Army Achievement Medal and Meritorious Service Medal.